Prat-Aymerich C, Yeghiazaryan L, Pathirana RD, Gautier V, et al. A prematurely terminated phase 2, randomised trial to evaluate immunogenicity and reactogenicity of a single versus two-dose primary vaccination regimen of the mRNA vaccine BNT162b2 in previously SARS-CoV-2 infected children 5-11 years old (CoVacc tri Vaccine 2026;88:128769.
PMID: 42364277